Search
Powered By HealthLine
Special Offers
Health Tools
 Allergy Questions and Answers
 Allergic Reaction Guide
 Seasonal Allergies Guide
 Is it a Cold or Allergies?
 Food Allergy Guide
Featured Conditions
 Allergy
 Asthma
 Diet & Exercise
 Sleep
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Studies Ignite Hope for Long-Acting Allergy Vaccines

New ragweed regimens would be more convenient and effective, researchers say

By Karen Pallarito
HealthDay Reporter


Related Encyclopedia
 border=
Allergic Rhinitis
Allergies
Allergies To Animals In Children
Allergy Immunotherapy
More...

Related Healthscout Videos
 border=
NEW ALLERGY DROPS
Antibiotic Mist for Sinus Problems
Stopping Allergies Before They Start
Knocking Out Allergic Asthma
More...

Related Animations
 border=
Allergy
More...

Related Drug Information
 border=
Allegra
Allegra D
Clarinex
Flonase
More...

Related News Articles
 border=
Prenatal Nutrition, Postnatal Allergy Protection
Lingering Cold Symptoms May Mean Sinusitis
Antifungal Drug May Help Ease Asthma
Climate Change May Boost Contact With Pollutants
More...

SUNDAY, Sept. 28 (HealthDay News) -- A vaccine that protects against the miserable symptoms of ragweed allergy for a longer period of time -- and with fewer injections -- could be available in the coming years.

Unlike traditional allergy vaccines that are given weekly for several months, new formulations would require only a few injections and would offer longer-lasting relief.

Text Continues Below



"What you would hope is that you would get fewer injections less often, less likelihood of an allergic reaction and the same or better improvement in your symptoms," said Dr. William C. Howland III, an allergist and medical director of Lovelace Scientific Resources in Austin, Texas.

Howland has presented research at an American College of Allergy, Asthma & Immunology meeting showing that just four injections of an investigational ragweed vaccine, called Pollinex Quattro, were safe and effective.

Separately, a research team led by Dr. Peter Creticos, clinical director of the Johns Hopkins Asthma and Allergy Center in Baltimore, has led pilot testing of another ragweed vaccine, called Tolamba, developed by Berkeley, Calif.-based Dynavax Technologies Corp. Those results were published recently in the New England Journal of Medicine.

"Our study was able to demonstrate that after a concise six-week, six-injection regimen, we were able to shut off seasonal symptoms for at least the two seasons we followed the patients in the study," Creticos said.

Ragweed is a type of weed that grows throughout the United States but is most common in the eastern states and in the Midwest. Among Americans who are allergic to pollen-producing plants, 75 percent are allergic to this particular weed, according to the Asthma and Allergy Foundation of America.

Ragweed season typically runs from mid-August to October and is a significant cause of fall allergy symptoms, says the American Academy of Allergy, Asthma & Immunology.

Page:  1 | 2 | 3 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 9/28/2008

Related Links
 border=
From Healthscout's partner site on allergy, MyAllergyNetwork.com
QUIZ: Test your knowledge of allergy causes and treatments
DRUGS: Common drugs used to treat allergies
SYMPTOMS: Images and information on allergy symptoms





SOURCES: Thomas B. Casale, M.D., professor of medicine, and chief, Division of Allergy and Immunology, Creighton University School of Medicine; Omaha, Neb.; William C. Howland III, M.D., allergist, and medical director, Lovelace Scientific Resources, Austin, Texas; Peter Creticos, M.D., clinical director, Johns Hopkins Asthma and Allergy Center, Baltimore; Asthma and Allergy Foundation of America, Washington, D.C.; American Academy of Allergy, Asthma & Immunology, Milwaukee; Allergy Therapeutics PLC, West Sussex, United Kingdom; Dynavax Technologies Corporation, Berkeley, Calif.


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service